Abstract
The purpose of this study was to determine whether rats could be trained to discriminate the stimulus properties of the benzodiazepine (BZ) receptor inverse agonist DMCM from saline in a conditioned taste aversion paradigm. On a drug trial, water-deprived rats were injected with DMCM (0.55–0.6 mg/kg IP), allowed access to a 0.25% saccharin solution for 30 min, and then injected with LiCl. On non-drug trials, saline injections bracketed the drinking period. Conditioned controls were treated similarly with DMCM and saline on drug and non-drug trials, but received injections of saline instead of LiCl. At the completion of training, DMCM produced a 69% reduction of saccharin consumption on drug trials, compared with 23% for conditioned controls. The stimulus properties of DMCM were then measured by its ability to reduce the preference for saccharin over water in a two-bottle choice test. DMCM reduced saccharin preference in rats that received discrimination training from 68% to 19%, but did not alter saccharin preference in conditioned controls. Other compounds with varying activity at BZ receptors were evaluated for their ability to substitute for the discriminative stimulus effects of DMCM. Two BZ receptor inverse agonists, β-CCE (10–18 mg/kg) and FG 7142 (3.2–18 mg/kg), substituted completely for DMCM. Partial substitution for DMCM was shown by the BZ receptor antagonist CGS 8216 (3.2–10 mg/kg) and the non-BZ convulsant pentylenetetrazol (10–20 mg/kg). The BZ receptor agonists chlordiazepoxide (0.32–5.0 mg/kg), diazepam (0.32–10 mg/kg), and alprazolam (0.1–3.2 mg/kg) and the BZ receptor antagonist flumazenil (1.0–32 mg/kg) failed to substitute for the DMCM stimulus. Pretreatment with flumazenil (1.0 mg/kg) blocked the stimulus effects of the training dose of DMCM and produced a shift to the right of the DMCM generalization curve. The pattern of compounds that substituted for the DMCM stimulus and the blockade of that stimulus by flumazenil indicate that the stimulus properties of DMCM are associated with its effects as a BZ receptor inverse agonist.
Similar content being viewed by others
References
Ator NA, Griffiths RR (1985) Lorazepam and pentobarbital discrimination: interactions with CGS 8216 and caffeine. Eur J Pharmacol 107:169–181
Braestrup C, Nielsen M (1983) Benzodiazepine receptors. In: Iversen LL, Iversen SD, Snyder, SH (eds) Handbook of psychopharmacology, vol 17. Plenum, New York, pp 285–384
Braestrup C, Schniechen R, Neef G, Nielsen M, Petersen EN (1982) Interactions of convulsive ligands with benzodiazepine receptors. Science 216:1241–1243
Braestrup C, Nielsen M, Honore T, Jensen LH, Petersen EN (1983) Benzodiazepine receptor ligands with positive and negative efficacy, Neuropharmacology 22:1451–1457
Costa E, Alho H, Favaron M, Manev H (1989) Pharmacological implications of the allosteric modulation of neurotransmitter amino acid receptors. In: Barnard EA, Costa E (eds) Allosteric modulation of amino acid receptors: therapeutic implications. Raven, New York, pp 3–18
Dorow R, Horowski R, Paschelke G, Amin M, Braestrup C (1983) Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet II: 98–99
Estall LB, Cooper SJ (1987) Differential effects of benzodiazepine receptor ligands on isotonic saline and water consumption in water-deprived rats. Pharmacol Biochem Behav 26:247–252
File SE (1983) Proconvulsant action of CGS 8216. Neurosci Lett 35:317–320
File SE, Baldwin HA (1987) Effects of beta-carbolines in animal models of anxiety. Brain Res Bull 19:293–299
File SE, Lister RG, Nutt DJ (1982) The anxiogenic actions of benzodiazepine antagonists. Neuropharmacology 21:1033–1037
Jaeger TV, Mucha RF (1990) A taste aversion model of drug discrimination learning: training drug and condition influence rate of learning, sensitivity, and drug specificity. Psychopharmacology 100:145–150
Jensen LH, Petersen EN, Honore T, Drejer J (1986) Bidirectional modulation of GABA function by beta-carbolines. In: Biggio G, Costa E (eds) GABAergic transmission and anxiety, vol 41. Raven, New York, pp 79–89
Kautz M, Gefer B, McBride S, Mastropaolo JP, Riley AL (1989) Naloxone as a stimulus for drug discrimination learning. Drug Dev Res 16:317–326
Lal H, Emmett-Oglesby MW (1983) Behavioral analogues of anxiety. Neuropharmacology 22:1423–1442
Leidenheimer NJ, Schechter MD (1988) Discriminative stimulus control by the anxiogenic beta-carboline FG 7142: generalization to a physiological stressor. Pharmacol Biochem Behav 30:351–355
Leidenheimer NJ, Schechter MD (1991) Inverse agonist properties of the FG 7142 discriminative stimulus. Pharmacol Biochem Behav 38:99–104
Lucki I (1988) Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion. J Pharmacol Exp Ther 247:1120–1127
Lucki I, Marcoccia JM (1991) Discriminated taste aversion with a 5-HT agonist measured using saccharin preference. Behav Pharmacol 2:335–344
Martin GM, Gans M, van der Kooy D (1990) Discriminative properties of morphine that modulate associations between taste and lithium chloride. J Exp Psychol [Anim Behav] 16:56–68
Martin IL (1987) The benzodiazepines and their receptors: 25 years of progress. Neuropharmacology 26:957–970
Mastropaolo JP, Moskowitz KH, Dacanay RJ, Riley AL (1989) Conditioned taste aversions in rats as a behavioral baseline for drug discrimination learning: An assessment with phencyclidine. Pharmacol Biochem Behav 32:1–8
Nielsen EB, Jepsen SA, Nielsen M, Braestrup C (1985) Discriminative stimulus properties of methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate (DMCM), an inverse agonist at benzodiazepine receptors. Life Sci 36:15–23
Nielsen EB, Valentine JD, Holohean AM, Appel JB (1983) Benzodiazepine receptor mediated discriminative cues: effects of GABA-ergic drugs and inverse agonists. Life Sci 33:2213–2220
Ninan PT, Insel TM, Cohen RM, Cook JM, Skolnick P, Paul SM (1982) Benzodiazepine receptor-mediated experimental “anxiety” in primates. Science 218:1332–1334
Riley AL, Jeffreys RJ, Pournaghash S, Titley TL, Kufera AM (1989) Conditioned taste aversions as a behavioral baseline for drug discrimination learning: an assessment with the dipsogenic compound pentobarbital. Drug Dev Res 16:229–236
Rowan GA, Lucki I (1992) Discriminative stimulus properties of the benzodiazepine receptor antagonist flumazenil. Psychopharmacology 107:103–112
Sepinwall J, Cook L (1978) Behavioral pharmacology of antianxiety drugs. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol. 13. Plenum, New York, pp 345–393
Shannon HE, Herling S (1983) Discriminative stimulus effects of diazepam in rats: evidence for a maximal effect. J Pharmacol Exp Ther 227:160–166
Takada K, Winger G, Cook J, Larscheid P, Woods JH (1986) Discriminative and aversive properties of β-carboline-3-carboxylic acid ethyl ester, a benzodiazepine receptor inverse agonist, in rhesus monkeys. Life Sci 38:1049–1056
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kirby, L.G., Rowan, G.A., Smith, R.L. et al. Discriminative stimulus properties of the benzodiazepine receptor inverse agonist methyl-6,7-dimethoxy-4-ethyl-β-carboline-3-carboxylate (DMCM). Psychopharmacology 113, 351–360 (1994). https://doi.org/10.1007/BF02245209
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245209